The U.S.Food and Drug Administration has issued a public health advisory about potential risks of taking certain migraine medications – triptans – together with certain antidepressants. The advisory states, “A life-threatening condition called serotonin syndrome may occur when triptans are used together with a SSRI or a SNRI.”
Serotonin syndrome occurs when the body has too much of serotonin, a chemical found in the nervous system. Serotonin syndrome may be more likely to occur when starting or increasing the dose of a triptan, SSRI or SNRI. Symptoms of serotonin syndrome may include:
Original »
One Response for "FDA issues an advisory on the Use of Triptans and Antidepressants"
[...] on the Use of Triptans and Antidepressants December 31, 1969 4:00 pm free medical excuse forms admin had an interesting blog post (FDA issues an advisory on the Use of Triptans and [...]
Leave a reply